- Home
- SCWO vs HOWL Comparison
SCWO vs HOWL Comparison
Compare SCWO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- HOWL
- Stock Information
- Founded
- SCWO 2021
- HOWL 2017
- Country
- SCWO United States
- HOWL United States
- Employees
- SCWO N/A
- HOWL N/A
- Industry
- SCWO Environmental Services
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- HOWL Health Care
- Exchange
- SCWO Nasdaq
- HOWL Nasdaq
- Market Cap
- SCWO 39.9M
- HOWL 37.9M
- IPO Year
- SCWO N/A
- HOWL 2021
- Fundamental
- Price
- SCWO $0.32
- HOWL $0.87
- Analyst Decision
- SCWO
- HOWL Strong Buy
- Analyst Count
- SCWO 0
- HOWL 3
- Target Price
- SCWO N/A
- HOWL $9.00
- AVG Volume (30 Days)
- SCWO 170.6K
- HOWL 232.7K
- Earning Date
- SCWO 05-15-2025
- HOWL 05-08-2025
- Dividend Yield
- SCWO N/A
- HOWL N/A
- EPS Growth
- SCWO N/A
- HOWL N/A
- EPS
- SCWO N/A
- HOWL N/A
- Revenue
- SCWO $445,445.00
- HOWL $1,143,000.00
- Revenue This Year
- SCWO $5,945.19
- HOWL N/A
- Revenue Next Year
- SCWO $106.82
- HOWL $733.33
- P/E Ratio
- SCWO N/A
- HOWL N/A
- Revenue Growth
- SCWO N/A
- HOWL N/A
- 52 Week Low
- SCWO $0.25
- HOWL $0.60
- 52 Week High
- SCWO $1.99
- HOWL $6.34
- Technical
- Relative Strength Index (RSI)
- SCWO 54.08
- HOWL 46.85
- Support Level
- SCWO $0.26
- HOWL $0.80
- Resistance Level
- SCWO $0.29
- HOWL $0.97
- Average True Range (ATR)
- SCWO 0.03
- HOWL 0.07
- MACD
- SCWO 0.01
- HOWL 0.02
- Stochastic Oscillator
- SCWO 70.00
- HOWL 41.92
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.